ÂÜÀòÂÒÂ×

Jonathan Mow is an experienced executive in the biotechnology and pharmaceuticals industries, currently serving as the Chief Executive Officer of VERALOX Therapeutics. Previously, Jonathan held the role of Chief Executive Officer and Chief Business Officer at PhaseBio Pharmaceuticals, Inc., as well as the position of VP Business Development at Amylin Pharmaceuticals. Jonathan co-founded Corus Pharma and served as the VP of Commercial and Business Development, and held the role of Sr. Director of Business Development at PathoGenesis Corp. Jonathan earned a Master of Business Administration from Carnegie Mellon University’s Tepper School of Business and a Bachelor of Science in Mechanical Engineering from the University of California, Berkeley.